Status:

COMPLETED

Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.

Lead Sponsor:

Rigshospitalet, Denmark

Collaborating Sponsors:

Linde AG

Conditions:

Anaesthesia

Postoperative Cognitive Function

Eligibility:

All Genders

60+ years

Phase:

PHASE3

Brief Summary

The primary objective was to explore the feasibility of inhaled xenon for sedation in terms of its effect on postoperative cognitive function in elderly, in comparison with the postoperative cognitive...

Detailed Description

Primary endpoint: - The primary efficacy parameter was a combined score based on the seven variables derived from four validated neuropsychological tests of cognitive function; Visual Verbal Learning ...

Eligibility Criteria

Inclusion

  • Male or female subjects ≥ 60 years of age.
  • American Soc. of Anaesthesiologists Physical Status Classification (ASA) I-III status \[27\]
  • Referred for elective orthopaedic knee surgery with an anticipated duration of \> 45 min
  • Expected to remain in hospital for at least 3 days
  • Expected to be able to comply with the study protocol throughout the study period
  • Mini Mental State Examination (MMSE) score \> 23
  • Informed consent given

Exclusion

  • Disease of the CNS (infectious, metabolic, tumours, dementia, epilepsy, major psychiatric disease, confusion/ delirium according to Diagnostic \& Statistical Manual of Mental Disorders (DSM) IV criteria)
  • Contradiction for spinal anaesthesia
  • Contradiction for laryngeal mask
  • Regular use of tranquillisers, or antidepressants, if prescribed by psychiatrist for psychosis or depression
  • Undergone neuropsychological testing within the last year
  • Unable to follow study procedures, illiteracy, or poor comprehension of the language used in the psychometric tests
  • Severe visual or auditory disorder
  • Alcoholism or drug abuse
  • CNS disease BMI \> 35 Inab

Key Trial Info

Start Date :

March 1 2004

Trial Type :

INTERVENTIONAL

End Date :

December 1 2004

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT00192959

Start Date

March 1 2004

End Date

December 1 2004

Last Update

September 19 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rigshospitalet

Copenhagen, Denmark, 2100